Whistleblower Lawsuit Related to Cancer Drug Marketing Leads to Celgene Paying $280 Million
- posted: Nov. 16, 2017
- Whistleblower Litigation
Celgene Corporation, a biotech company based in New Jersey, will pay out $280 million to settle claims that it cited uses not approved by the U.S. Food and Drug Administration Read More